% Expired Patents = 12.5

CIPO Patents = 2

EPO Patents = 4

Forward Citations = 7

Loading Chart...

2 inventors (with patents filed for the assignee):

Mariusz Szkudlinski (8 out of 8 patents)

Bruce D Weintraub (8 out of 14 patents)

Mariusz W Szkudlinski (4 patents)

8 patents: Sort by Forward Citations

1. 10766941 - Glycoprotein hormone long-acting superagonists (2020-09-08),

2. 10544200 - Glycoprotein hormone long-acting superagonists (2020-01-28),

3. 10457713 - Glycoprotein hormone long-acting superagonists (2019-10-29),

4. 9249205 - Glycoprotein hormone long-acting superagonists (2016-02-02),

5. 9187545 - Glycoprotein hormone long-acting superagonists (2015-11-17),

6. 9078860 - VEGF analogs (2015-07-14),

7. 8759285 - VEGF superagonists and methods of use (2014-06-24),

8. 8377879 - Follicle stimulating hormone superagonists (2013-02-19),

Trophogen Inc. is a biotechnology company focused on developing innovative therapies for cancer. With a team of experienced researchers and scientists, Trophogen is dedicated to advancing novel treatments that target specific pathways in cancer cells. The company's mission is to improve patient outcomes and quality of life through cutting-edge research and development.

Profile summary based on public USPTO records.